Product
lirentelimab
1 clinical trial
2 indications
Indication
Eosinophilic GastritisIndication
Eosinophilic DuodenitisClinical trial
A Phase 3, Multicenter, Open-Label, Extension Study to Evaluate the Efficacy and Safety of AK002 in Patients That Were Previously Enrolled in AK002-016 or AK002-012 Studies and Have Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)Status: Completed, Estimated PCD: 2023-05-15